Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00154089 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
A Phase 1 study, sponsored by Erimos Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00154089 is a Phase 1 study that has completed, run by Erimos Pharmaceuticals. The registered enrollment target is 8 participants.
The verdict
NCT00154089, a Phase 1 study, has completed, sponsored by Erimos Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine pilot safety and efficacy data for a topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.
Interventions
- DRUG EM-1421
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00154089
The ClinicalTrials.gov registry entry for NCT00154089 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erimos Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EM-1421 is the first listed.
NCT00154089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00154089 about?
NCT00154089 is a clinical study titled "A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia". The primary objective of this study is to determine pilot safety and efficacy data for a topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.
What is the current status of trial NCT00154089?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2004-11. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00154089?
The interventions under investigation include: EM-1421 (DRUG).
Who is sponsoring clinical trial NCT00154089?
This trial is sponsored by Erimos Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.